These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2009-017415-16 A Phase III, single-center, randomized, double-blind, parallel group, placebo-controlled study of Alpicort F in the treatment of chemotherapy induced alopecia in women 2011-04-29 due-trials
Reported results 2010-023494-19 A Phase IIa, Multi-Centre, Double-blind, Randomised, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of K(D)PT after Multiple Ascending Doses in Patients with Active M... 2011-08-07 due-trials
Reported results 2010-024572-25 Local antibacterial efficacy of a gel containing 0.1 % octenidine dihydrochloride on pre-damaged skin 2011-05-31 due-trials
Reported results 2011-002462-20 Randomised, double-blind, placebo-controlled prospective clinical trial to evaluate the efficacy and safety of K(D)PT in patients with mild to moderate ulcerative colitis 2013-04-03 due-trials
Reported results 2011-002464-24 Clinical study to investigate the efficacy and safety of an estradiol containing cream (0.01 % estradiol) in patients with dermatoporosis 2011-12-14 due-trials
Completed, but no date, and reported results 2016-002199-28 Prospective, open-label, multicenter, multinational, randomized trial to investigate the non-inferiority of treatment with Vagisan® Moisturising Cream in comparison to an Estriol containing cream in a... bad-data
Listed as ongoing, but also has a completion date and reported results 2017-004534-28 Combined Randomized, Double-Blind, Dose-Confirming Phase 3a Study in Parallel Design to Assess the Efficacy and Safety of Topical 4-Week Treatment With 1% GPB Cream vs Placebo and Open-Label Phase 3b... 2022-02-02 bad-data
Reported results 2019-002325-30 Prospective, open-label, monocenter, trial to investigate the efficacy and tolerability of Vagisan® a lactic acid containing vaginal suppository, in a panel of post-menopausal women suffering from vu... 2020-08-11 due-trials
Completed, reported early 2022-000922-46 An Open-Label, Uncontrolled, Multicenter Study to Evaluate the Safety, Local Tolerability, Systemic Exposure, and Efficacy of 1% GPB Cream in Adolescents With Severe Primary Axillary Hyperhidrosis PI... 2024-03-06 not-yet-due